Spanish Biotech Stock News

Amadeus IT Group stock has quietly ground higher in recent months, with a 3 month gain of about 8.9% and a close at €53.34 on 31 July. The market has been rewarding the story. The headline from this earnings release is more nuanced. Revenue for Q1 2026 sat at €1,682.6m and basic earnings per share were €0.83, while management kept free cash flow and margin discipline in clear focus. The real question now is whether that cash generation and margin profile justify the current P/E of 16.1x over...

Meliá Hotels International stock has cooled off into late July, with shares down about 13% over the past month and 7% over the last quarter. Yet the latest earnings story is less about the share price and more about pressure on profitability. The headline is margin strain. Quarterly net income has swung toward breakeven territory even as the trailing 12 month net profit margin sits at 7.8%. For investors with a longer lens, the key question now is how that margin profile and the company’s...

Banco Bilbao Vizcaya Argentaria (BME:BBVA) stock is in focus after the bank reported second quarter 2026 net income of €3,062 million and announced a new €2b share buyback alongside higher regional guidance. See our latest analysis for Banco Bilbao Vizcaya Argentaria. Banco Bilbao Vizcaya Argentaria’s latest results and €2b buyback have landed after a strong run, with a 10.25% 1 month share price return and a 75.63% 1 year total shareholder return signalling strong momentum built over several...

Iberdrola (BME:IBE) drew investor attention after reporting half year 2026 results, with sales of €22,469.1m, net income of €4,336.4m and basic earnings per share of €0.622. See our latest analysis for Iberdrola. Iberdrola’s latest half year results and the recent Caruna Oy acquisition discussion come as the share price sits at €20.65, with year to date share price return of 10.84% and a 5 year total shareholder return of 140.89%. If these results have you thinking about other electricity and...

Why Mapfre’s Latest Earnings Matter For Shareholders Mapfre (BME:MAP) is in focus after reporting half year 2026 earnings, with net income of €646.2m and basic earnings per share from continuing operations of €0.21 compared to €0.19 a year earlier. See our latest analysis for Mapfre. The latest half year 2026 earnings update appears to have supported positive sentiment in Mapfre, with a 1 day share price return of 0.77% and a 90 day share price return of 6.43%, while the 5 year total...

It's been a good week for Viscofan, S.A. ( BME:VIS ) shareholders, because the company has just released its latest...

A week ago, Endesa, S.A. ( BME:ELE ) came out with a strong set of interim numbers that could potentially lead to a...

Last week saw the newest half-yearly earnings release from Pharma Mar, S.A. ( BME:PHM ), an important milestone in the...

Why CaixaBank’s Latest Earnings Matter For Shareholders CaixaBank (BME:CABK) is in focus after reporting second quarter 2026 net income of €1,631 million, up from €1,482 million a year earlier, with six month profit also higher year on year. See our latest analysis for CaixaBank. CaixaBank’s latest earnings update comes after a strong run for investors, with the stock delivering a 15.91% 90 day share price return and a very large 5 year total shareholder return, even though the 7 day share...

Clínica Baviera stock closed at €59.60 on 31 July, roughly flat over the past month, even as the latest half year results sharpened the focus on profitability. Behind the muted price action sits a business that just booked €320.67m in trailing twelve month revenue and €2.87 in basic earnings per share. That earnings power feeds into a trailing P/E of 20.8x, only slightly above the wider European healthcare group and well below a much richer peer set. The real headline for long term holders is...

Prosegur Cash walked into this earnings day with a cheap looking P/E of 10.8x and a share price that had crept up about 7.7% over the past month. The stock now sits at €0.669, yet the headline from the quarter is not the price chart. It is the quiet squeeze in profitability. Quarterly revenue held around €503.5m, but basic earnings per share slipped to €0.011646 as net income eased to €21.5m. The market is reacting to a low priced stock. The real story is whether this margin and profit...

Fluidra’s stock closed at €19.28 after this latest print, roughly flat over the past week and still down over the past month. That muted reaction sits awkwardly against a quarter that showed the pool equipment group putting real earnings power back on the table. Q2 revenue reached €724.2m and basic earnings per share came in at €0.42, with adjusted earnings for the first half rising and free cash flow turning positive. The market is still treating Fluidra as a slow grind story. The headline...

Cellnex Telecom shares came into this earnings print with a mixed recent run, slightly higher over one and three months but weaker over the past quarter. The stock closed at €26.87, with investors already wrestling with a premium price to sales multiple of 4.3x compared with peers around 1.2x to 1.3x. The headline from this report is not the top line. It is the ongoing loss, with Q2 net income excluding extra items at a loss of €60m and trailing twelve month losses of €342.8m. The market now...

Técnicas Reunidas came into this earnings day with a bruised share price, down roughly 20% over three months, yet trading on a modest 14x P/E and far below one prominent fair value estimate. The stock closed at €28.28 after the release, as investors weighed headline growth against lingering project risk. The real story in this quarter is profit quality. Q2 revenue of €1,478.1m and net income of €44.4m sit within a half year that includes a €45m provision linked to the Middle East conflict,...

Sacyr entered this earnings week with the stock treading water, up only slightly over the past month and almost flat over three months. That calm surface hides a much stronger profit story underneath. Q2 basic earnings per share came in at €0.051, ahead of Q1, and net income reached €40.8m on revenue of €1.32b. The headline this quarter is profit momentum in a business often treated as a slow, contract driven grinder. The next sections unpack whether that earnings strength justifies where the...

BBVA stock closed at €24.2 after the market weighed in on its Q2 2026 numbers that delivered a punchy headline. The group posted net income of €3.062b for the quarter and €6.051b for the first half, with return on tangible equity around the low 20s that management calls best in class among big European banks. Short term traders are focused on the recent double digit share price gains. Long term investors are looking at a bank combining strong profitability with rising loans and a growing...

ACS Actividades de Construcción y Servicios stock has drifted lower in recent weeks, down about 11% over the past month, even as the price sits near €110 after the latest results. The short term mood looks cautious, but the earnings print tells a different story. Q2 revenue reached about €13.8b with basic earnings per share just over €1.05, and trailing 12 month earnings now sit above €1b. The key point for ACS is valuation. The stock trades on a P/E above the European construction average,...

Cirsa Enterprises stock has climbed steadily into this earnings season, with gains over the past week and month setting expectations high. The headline is not the share price. It is the profit rebuild. Net income from continuing operations over the last twelve months now sits above €160m, with net profit margin at 4.7% compared with just 0.6% a year earlier. The market is treating Cirsa as a financially stretched casino operator, focused on weak interest and dividend coverage, while the core...

Puig Brands walked into this earnings day with a stock that had slipped over the past three months yet traded on a P/E well below peers and below some fair value estimates. That set the stage for an emotion heavy session. The headline from the numbers is clear. Record first half net revenues of €2.35b and an adjusted EBITDA margin of 19.5% landed alongside an adjusted net profit of €260m. Investors now need to decide whether a lower valuation still reflects caution or if today’s beauty...

MERLIN Properties SOCIMI (BME:MRL) has just reported its half year 2026 earnings, with higher sales, net income and earnings per share, and an increased full year FFO guidance that highlights current business momentum. See our latest analysis for MERLIN Properties SOCIMI. The current share price of MERLIN Properties SOCIMI at €14.86 comes after a 1-day share price return of 2.48%. The year to date share price return of 20.52% and 1-year total shareholder return of 25.39% indicate momentum...

Pharma Mar stock closed at €80.15 after the market absorbed its half year 2026 update, leaving investors weighing a flat near term share price against a very different earnings picture. The company delivered resilient recurring oncology revenues and stayed cash generative, yet quarterly profit slipped into a small loss of €0.972m even as trailing twelve month earnings from continuing operations reached €56.126m. The real story now sits on the longer horizon. Royalty growth, the Zepzelca...

Unsurprisingly, Laboratorios Farmaceuticos Rovi, S.A.'s ( BME:ROVI ) stock price was strong on the back of its healthy...

Repsol, S.A. ( BME:REP ) just reported healthy earnings but the stock price didn't move much. Investors are probably...

Sacyr (BME:SCYR) is back in focus after reporting half year 2026 results, with revenue and EBITDA up around 9%, net profit lifted by a Colombia divestment, and higher cash dividends attracting fresh investor attention. See our latest analysis for Sacyr. Sacyr’s recent half year 2026 earnings update comes after a strong run, with the share price at €4.824 and a year to date share price return of 22.87%, alongside a 1 year total shareholder return of 38.08% and 5 year total shareholder return...